[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0236 After discontinuation of the 1st tumor necrosis factor inhibitor (TNFI), non-tnfi biologic agents have similar responses but higher survival compared to a 2nd course of a different tnfi: long-term prospective observational study of patients with rheumatoid arthritis in a tertiary hospital of greece

• 作者Flouri, ID; Repa, A; Avgoustidis, N; Kougas, N; Fanouriakis, A; Papalopoulos, I; Adamichou, C; Kyfonidou, P; Kampouraki, E; Terizaki, M; Boumpas, DT; Bertsias, G; Sidiropoulos, P
• 文件大小108.13KB
• DOI10.1136/annrheumdis-2017-eular.6817
• 页码574-574